Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional Settings
To reduce overdose rates in the U.S., leaders must recognize the impact of medication-assisted treatment in correctional facilities.
The Broken Approach to Health Disparities
State, federal, and academic initiatives have poured time and resources into understanding and addressing these gaps. So why haven’t we made real, lasting progress?
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Cautious Pessimism – What Isn’t Being Talked About, And What It Means For Healthcare
The lessons learned and shared by some of the industry’s leaders are exciting, and some clear opportunities are developing. But under the surface, this year, there is something else, and I’m not sure it’s getting enough attention: anxiety.
Keys to Provider Patient Communications Amidst President Trump’s Massive Policy Shifts
Exactly what the administration is ultimately able to accomplish will be anyone’s guess, but here are some key policy and market shifts healthcare leaders and their PR teams should watch closely and be prepared to communicate around.
Prioritizing Care That Cures – Fighting the Epidemic With Opioid Treatment Programs
Policymakers should recognize the advantages of this multi-faceted care model and ensure legislative and regulatory environments allow for its continued growth.
The New Game Plan for Star Ratings Must Start with Member Incentives
Medicare Advantage plans can more effectively position themselves for success under an evolving measurement system. Here are three strategic actions health plan leaders should prioritize to enhance 2026 bids to secure stronger Star Rating performance.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
How Medicare Advantage Plans Can Prioritize Quality Amid Continued Turbulence
Organizations with underperforming Medicare Advantage plans can, and should, start taking steps now to establish a strong foundation that can sustain long-term success
Consumer Empowerment Closes Medicaid Member Care Gaps
While enrollment in consumer direction programs has grown, more must be done to educate, amplify, and spread awareness to ensure that all eligible individuals learn about the benefits of this alternative to traditionally delivered agency and institutional care.
Common MRF Mistakes Hospitals Are Making in 2024
Updated schema requirements are easy to mix up — here are a few simple solutions
Eliminating Barriers and Increasing Access to New Testing to Improve Prenatal Care
New advancements can only be fully realized when clinicians, lawmakers, and patients come together. Biomarker tests not only have the potential to improve patient outcomes and address health equity, they can also decrease expenses for financially vulnerable medical systems.
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Don’t Erode Medical Device Trust with Right to Repair
Right to repair would undermine the FDA’s regulations and introduce unnecessary risk into the healthcare industry, threatening the high-quality care that doctors provide patients.
Bundling Boomer Housing with On-site Primary Care and Wellness-Focused Living: It Just Makes Sense
Providing proactive and preventive health-focused living among younger, less affluent senior populations -- and extending this into value-based care -- just makes sense.
Where Medicare Advantage Goes From Here
Now is the time for health plans to step up and embrace the tools and strategies that will not only meet regulatory demands, but also drive innovation in care delivery.
Financial Security, Lasting Relief: How the Inflation Reduction Act Restores Health to Patients and Hope to Their Doctors
For those who rely on these treatments, affordable medication access is a matter of health, freedom, and dignity, and their mechanisms and outcomes are non-partisan.
Dear Mr. Buffett: Healthcare Isn’t Hopeless
Truth is, there are hugely positive tailwinds at our back. But the way we’ve been thinking about the problem is holding us back from solving it. Here’s why.